The pipeline data below are compiled from the Synapse database: In addition to single GLP-1R targets, GLP-1R combined with multi-target therapies has become a major direction in clinical development
Such effects are consistent with their established reduction in atherosclerotic cardiovascular events and may be particularly relevant in patients with obesity, insulin resistance, or HFpEF phenotypes, and taken together, these mechanistic differences provide a biologically plausible rationale for combination therapy: SGLT2 inhibitors primarily target HF-related hemodynamic and cardiorenal pathways, whereas GLP-1 receptor agonists may further improve metabolic and vascular risk
At the same time, longer-term tirzepatide studies show that weight changes continue over many months, even if the pace slows down
Liu Q, Zhu J, Kong B, Shuai W, Huang H
For pharmacies shipping large quantities or for patients who want to stock up, this is a practical advantage
While using Zepbound, keep an eye out for side effects, especially anything that could point to pancreatitis, like severe abdominal pain, nausea, or vomiting